Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials with Time-to-Event Outcomes under ICH E9 (R1)

Abstract

In randomized controlled trials (RCTs) that focus on time-to-event outcomes, intercurrent events can arise in two ways: as semi-competing events, which modify the hazard of the primary outcome events, or as competing events, which make the definition of the primary outcome events unclear. Although five strategies have been proposed in the ICH E9 (R1) addendum to address intercurrent events in RCTs, these strategies are not easily applicable to time-to-event outcomes when aiming for causal interpretations. In this study, we show how to define, estimate, and make inferences concerning objectives that have causal interpretations within these contexts. Specifically, we derive the mathematical formulations of the causal estimands corresponding to the five strategies and clarify the data structure needed to identify these causal estimands. Furthermore, we introduce nonparametric methods for estimating and making inferences about these causal estimands, including the asymptotic variance of estimators and hypothesis tests. Finally, we illustrate our methods using data from the LEADER Trial, which aims to investigate the effect of liraglutide on cardiovascular outcomes.

Accepted by Statistics in Medicine

References in corpus (11)

• Principal Stratum Strategy: Potential Role in Drug Development
• Treatment Effect Quantification for Time-to-event Endpoints -- Estimands, Analysis Strategies, and beyond
• Causal inference with recurrent and competing events
• Survivor average causal effects for continuous time: a principal stratification approach to causal inference with semicompeting risks
• Assessing causal effects in the presence of treatment switching through principal stratification
• Direct and Indirect Treatment Effects in the Presence of Semi-Competing Risks
• Principal stratification analysis using principal scores
• A Bayesian Nonparametric Approach for Evaluating the Causal Effect of Treatment in Randomized Trials with Semi-Competing Risks
• Bivariate copula regression models for semi-competing risks
• Defining and Estimating Subgroup Mediation Effects with Semi-Competing Risks Data
• Multistate Models as a Framework for Estimand Specification in Clinical Trials of Complex Processes